Zevra Therapeutics
ZVRA
ZVRA
84 hedge funds and large institutions have $83.5M invested in Zevra Therapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.39% less ownership
Funds ownership: 31.82% → 31.43% (-0.39%)
44% less call options, than puts
Call options by funds: $1.19M | Put options by funds: $2.11M
Holders
84
Holding in Top 10
–
Calls
$1.19M
Puts
$2.11M
Top Buyers
| 1 | +$3.54M | |
| 2 | +$1.76M | |
| 3 | +$1.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.09M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$951K |
Top Sellers
| 1 | -$298K | |
| 2 | -$150K | |
| 3 | -$109K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$67.4K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$52K |